Article citationsMore>>

Xu, B., Fang, J., Wang, J., Jin, X., Liu, S., Song, K., et al. (2023) Inhibition of Autophagy and RIP1/RIP3/MLKL-Mediated Necroptosis by Edaravone Attenuates Blood Spinal Cord Barrier Disruption Following Spinal Cord Injury. Biomedicine & Pharmacotherapy, 165, Article 115165.
https://doi.org/10.1016/j.biopha.2023.115165

has been cited by the following article:

• TITLE: Advances in Pharmacological Therapy for Spinal Cord Injury

  AUTHORS: Qiuyue Zheng, Senming Xu

  KEYWORDS: Spinal Cord Injury, Pharmacotherapy, Review

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.13 No.10, October 27, 2025

  ABSTRACT: Spinal cord injury (SCI) is a severe neurological disorder that can result in serious sequelae, significantly impacting patients’ quality of life. Current primary treatment modalities include surgery, pharmacotherapy, and hyperbaric oxygen therapy. Pharmacological interventions play a crucial role in the management of spinal cord injury. However, there is currently no unified and highly effective pharmacological treatment strategy available. Therefore, this article reviews the current status of drugs commonly used in the clinical treatment of spinal cord injury.